Intervention

External beam radiation therapy

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting0

Common conditions13

Lead sponsors shown5

Clinical trials

5 shown

Imaging and Genomic Biomarkers to Predict Response in Prostate CancerNCT05477823 · 2023-03-08

ACTIVE_NOT_RECRUITING

Prostate Margin Reduction to Reduce Acute Rectal Toxicity (PROTRACT)NCT04004858 · 2019-08-01

Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate CancerNCT02605226 · 2015-11-01

Accelerated Radiation Therapy After Surgery in Treating Patients With Breast CancerNCT01417286 · 2010-12-21

A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung CancerNCT00352690 · 2006-04-01

Common conditions

Prostate Cancer2 Carcinoma, Non-Small-Cell Lung1 Inflammatory Breast Cancer1 Invasive Ductal Breast Carcinoma1 Invasive Lobular Breast Carcinoma1 Mucinous Ductal Breast Carcinoma1 Papillary Ductal Breast Carcinoma1 Stage II Breast Cancer1 Stage III Prostate Cancer1 Stage IIIA Breast Cancer1 Stage IIIB Breast Cancer1 Stage IIIC Breast Cancer1 Tubular Ductal Breast Carcinoma1

Leading sponsors

Rutgers, The State University of New Jersey1 Southlake Health1 Tianjin Medical University Cancer Institute and Hospital1 University of Wisconsin, Madison1 Washington University School of Medicine1

Trial status mix

UNKNOWN2

ACTIVE_NOT_RECRUITING1

COMPLETED1

TERMINATED1

Phase mix

NA2

PHASE22

EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.